These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 11179738)

  • 1. Functions of 1alpha,25-dihydroxyvitamin D(3) in mammary gland: from normal development to breast cancer.
    Narvaez CJ; Zinser G; Welsh J
    Steroids; 2001; 66(3-5):301-8. PubMed ID: 11179738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targets of vitamin D receptor signaling in the mammary gland.
    Welsh J
    J Bone Miner Res; 2007 Dec; 22 Suppl 2():V86-90. PubMed ID: 18290729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of mammary tumor cell lines from wild type and vitamin D3 receptor knockout mice.
    Zinser GM; McEleney K; Welsh J
    Mol Cell Endocrinol; 2003 Feb; 200(1-2):67-80. PubMed ID: 12644300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mammary adipocytes bioactivate 25-hydroxyvitamin D₃ and signal via vitamin D₃ receptor, modulating mammary epithelial cell growth.
    Ching S; Kashinkunti S; Niehaus MD; Zinser GM
    J Cell Biochem; 2011 Nov; 112(11):3393-405. PubMed ID: 21769914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D metabolism in mammary gland and breast cancer.
    Welsh J
    Mol Cell Endocrinol; 2011 Dec; 347(1-2):55-60. PubMed ID: 21669251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of Vitamin D compounds to modulate estrogen receptor negative breast cancer growth and invasion.
    Flanagan L; Packman K; Juba B; O'Neill S; Tenniswood M; Welsh J
    J Steroid Biochem Mol Biol; 2003 Feb; 84(2-3):181-92. PubMed ID: 12711002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of the Vitamin D3 receptor on growth-regulatory pathways in mammary gland and breast cancer.
    Welsh J; Wietzke JA; Zinser GM; Smyczek S; Romu S; Tribble E; Welsh JC; Byrne B; Narvaez CJ
    J Steroid Biochem Mol Biol; 2002 Dec; 83(1-5):85-92. PubMed ID: 12650704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Function of the vitamin D endocrine system in mammary gland and breast cancer.
    Welsh J
    Mol Cell Endocrinol; 2017 Sep; 453():88-95. PubMed ID: 28579119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin D, Pit-1, GH, and PRL: possible roles in breast cancer development.
    Perez-Fernandez R; Seoane S; Garcia-Caballero T; Segura C; Macia M
    Curr Med Chem; 2007; 14(29):3051-8. PubMed ID: 18220741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin D and breast cancer: insights from animal models.
    Welsh J
    Am J Clin Nutr; 2004 Dec; 80(6 Suppl):1721S-4S. PubMed ID: 15585794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1α,25 dihydroxi-vitamin D₃ modulates CDK4 and CDK6 expression and localization.
    Irazoqui AP; Heim NB; Boland RL; Buitrago CG
    Biochem Biophys Res Commun; 2015 Mar; 459(1):137-42. PubMed ID: 25721671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast cancer cell regulation by high-dose Vitamin D compounds in the absence of nuclear vitamin D receptor.
    Valrance ME; Welsh J
    J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):221-5. PubMed ID: 15225775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VDR in salivary gland homeostasis and cancer.
    DeSantis KA; Robilotto SL; Matson M; Kotb NM; Lapierre CM; Minhas Z; Leder AA; Abdul K; Facteau EM; Welsh J
    J Steroid Biochem Mol Biol; 2020 May; 199():105600. PubMed ID: 31958633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin D(3) receptor ablation alters mammary gland morphogenesis.
    Zinser G; Packman K; Welsh J
    Development; 2002 Jul; 129(13):3067-76. PubMed ID: 12070083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stable expression of human VDR in murine VDR-null cells recapitulates vitamin D mediated anti-cancer signaling.
    Keith ME; LaPorta E; Welsh J
    Mol Carcinog; 2014 Apr; 53(4):286-99. PubMed ID: 23681781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms implicated in the growth regulatory effects of vitamin D in breast cancer.
    Colston KW; Hansen CM
    Endocr Relat Cancer; 2002 Mar; 9(1):45-59. PubMed ID: 11914182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin D and prevention of breast cancer.
    Welsh J
    Acta Pharmacol Sin; 2007 Sep; 28(9):1373-82. PubMed ID: 17723171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative regulation of gene expression by 1,25-dihydroxyvitamin D3 in cells derived from normal mammary tissue and breast cancer.
    Beaudin SG; Robilotto S; Welsh J
    J Steroid Biochem Mol Biol; 2015 Apr; 148():96-102. PubMed ID: 25239595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Actions of 1,25(OH)2-vitamin D3 on the cellular cycle depend on VDR and p38 MAPK in skeletal muscle cells.
    Irazoqui AP; Boland RL; Buitrago CG
    J Mol Endocrinol; 2014 Dec; 53(3):331-43. PubMed ID: 25316911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemoprevention of mammary carcinogenesis by 1alpha-hydroxyvitamin D5, a synthetic analog of Vitamin D.
    Mehta RG; Hussain EA; Mehta RR; Das Gupta TK
    Mutat Res; 2003; 523-524():253-64. PubMed ID: 12628523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.